PLIVA 459 (Theophylline extended-release 300 mg)
Pill with imprint PLIVA 459 is White, Capsule-shape and has been identified as Theophylline extended-release 300 mg. It is supplied by Pliva Inc..
Theophylline is used in the treatment of asthma, maintenance; apnea of prematurity; asthma, acute and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PLIVA 459
Theophylline extended-release
- Imprint:
- PLIVA 459
- Strength:
- 300 mg
- Color:
- White
- Size:
- 14.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Methylxanthines
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Pliva Inc.
- Inactive Ingredients:
- hypromellose 2208 (100 mPa.s)
hypromellose 2208 (100000 mPa.s)
lactose anhydrous
magnesium stearate
povidone
Note: Inactive ingredients may vary.
More about theophylline
- Theophylline Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 9 Reviews – Add your own review/rating
- Drug class: methylxanthines
Consumer resources
- Theophylline
- Theophylline Injection
- Theophylline Sustained-Release Tablets
- Theophylline Sustained-Release Capsules
- Theophylline Liquid
- ... +2 more
Other brands: Theo-Dur, Theo-24, Elixophyllin, Uniphyl, ... +6 more
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
